Astria Therapeutics, Inc.
Clinical trials sponsored by Astria Therapeutics, Inc., explained in plain language.
-
New hope for HAE sufferers: Long-Term drug trial launches
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of a drug called navenibart for people with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. It is for adults and teens who were in a previous navenibart study. Participants will receive navenib…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 10:51 UTC
-
New drug STAR-0310 tested in healthy volunteers for first time
Knowledge-focused OngoingThis early-stage study tests a new drug called STAR-0310 in healthy adults to see if it is safe and how the body processes it. About 40 participants will receive either a single dose of the drug or a placebo. The study aims to gather initial safety data before testing in patients…
Phase: PHASE1 • Sponsor: Astria Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC